A Prospective, Observational Study to Monitor Safety in Patients Who Were Administered With Pneumococcal Conjugate Vaccine, 7-Valent (Prevenar) 0.5 mL by Intramuscular Injection.
Phase of Trial: Phase IV
Latest Information Update: 15 Nov 2010
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions
- Sponsors Wyeth
- 15 Nov 2010 Actual patient number (3366) added as reported by ClinicalTrials.gov.
- 16 Dec 2009 Actual patient number (3468) added as reported by ClinicalTrials.gov.
- 16 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.